Toxic Shock Syndrome due to Streptococcus Pyogenes: Case Report

Toxic shock syndrome (TSS) is one of the most devastating clinical manifestations of Streptococcus pyogenes (also known as Group A Streptococci or GAS), characterized by an overwhelming production of toxins. The incidence of TSS is increasing worldwide, and the mortality rate remains unacceptably high. Due to the rapid progression of infection, rapid diagnosis is crucial, as early initiation of aggressive supportive measures, along with antibiotics, source control, immunoglobulin, and steroids, can improve patient outcomes. IgM- and IgA-enriched immunoglobulins represents a new therapeutic option, as highlighted in the case reported here.

A 66-year-old man was admitted for cellulitis of the right arm with shock, disseminated intravascular coagulation (DIC), renal and hepatic compromise, suggestive of toxic shock syndrome (TSS). Blood cultures revealed S. pyogenes, confirming the diagnosis. The patient was treated with combination antibiotic therapy (clindamycin, piperacillin/tazobactam), steroids and enriched immunoglobulins in addition to vasopressor and high flow oxygen. He was discharged home with complete recovery after 1 month. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: In the emergency department, the primary goals of management of TSS include aggressive resuscitation, prompt administration of appropriate antibiotics, source control if feasible, and early intensive care unit admission.